See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516479_2016_Insys_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 251.26618705035972, 'aggregate_val': 210390000, 'exp_sum': 834000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 834000}} |
Graph
Absolute values for 0001516479, Insys Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 253,238,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 38,382,000 |
| 3 | remainder_Assets | 59,576,000 |
| 4 | LiabilitiesCurrent | 88,859,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,635,000 |
| 7 | CostOfGoodsAndServicesSold | 28,854,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 64,049,000 |
| 9 | ResearchAndDevelopmentExpense | 55,281,000 |
| 10 | remainder_Expenses | 124,675,000 |
| 11 | remainder_Revenues | 330,797,000 |
| 12 | remainder_NetIncome | 538,000 |
| 13 | remainder_ComprehensiveNetIncome | -128,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 351,196,000 |
| 1 | Liabilities | 97,494,000 |
| 2 | Expenses | 272,859,000 |
| 3 | Revenues | 330,797,000 |
| 4 | StockholdersEquity | 253,702,000 |
| 5 | NetIncome | 58,476,000 |
| 6 | ComprehensiveNetIncome | 58,412,000 |
| 7 | BaseVar | 526,506,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.73 |
| 9 | EconomicCapitalRatio | 3.50 |
Edgar->Model Mapping
Feature Distribution
Change over Time
